SOY HEART HEALTH INTRODUCTION
|
|
- Jasper Miller
- 5 years ago
- Views:
Transcription
1 SOY HEART HEALTH TRENDS AND RATES RISK FACTORS DIETARY CHOICES CIRCULATING LIPID LEVELS OMEGA-3 & OMEGA-6 FATTY ACIDS SOYFOODS CAN MAKE IMPORTANT CONTRIBUTIONS TO HEART-HEALTHFUL DIETS, INCLUDING HIGH- QUALITY PROTEIN AND AMPLE AMOUNTS OF OMEGA-6 AND OMEGA-3 ESSENTIAL FATTY ACIDS. INTRODUCTION Coronary artery disease and stroke account for over 20% of deaths worldwide 1 but there are striking variations in age-adjusted cardiovascular disease (CVD) mortality rates among countries. These international variations are not due to genetic differences among populations. This is evident from trends in rates within countries and changes in rates among migrants moving from low-risk to high-risk countries. The United States has one of the highest rates of CVD in the world. 2 In the most recent year for which data are available, an estimated 15.5 million Americans were affected by coronary heart disease (CHD) alone, which includes myocardial infarction and angina pectoris. Heart disease strikes someone in the United States every 42 seconds and kills more than 370,000 Americans each year. 3 Approximately one in seven deaths in the United States is from CHD, which makes it the number-one killer of Americans ,000 Americans have a new coronary attack (defined as first hospitalized myocardial infarction or coronary heart disease death) each year ,000 people have a recurrent coronary attack ,000 people experience silent first myocardial infarctions each year. 3 The number of coronary deaths divides approximately evenly between men and women, although the average age of a first heart attack is approximately 64 for men and 70 for women. On the other hand, risk factors such as high blood pressure and diabetes increase heart attack risk in women more severely than in men. 4 1
2 In 2013, the American Heart Association (AHA) issued new guidelines for the assessment of CVD risk. 5 According to the AHA, in addition to age and gender, risk is primarily determined by total cholesterol level, HDL-cholesterol, systolic blood pressure, and whether one smokes and has diabetes. Evidence indicates that adjusted population attributable fractions for CHD mortality are as follows: 34.7% for high blood pressure 16.7% for smoking 20.6% for poor diet 7.8% for insufficient physical activity 7.5% for abnormal glucose levels From the information above, it is clear that dietary choices can significantly impact the risk of developing CHD. While markedly reducing CHD risk via dietary modification requires a comprehensive approach, there is no doubt that soyfoods can play an important role in heart-healthy diets. EFFECTS OF SOYFOODS ON CIRCULATING LIPID LEVELS Soyfoods have been recognized by nutritionists for decades as rich sources of high-quality protein, but over the past 20 years the effect of soy protein on blood cholesterol levels has attracted attention from the nutrition and medical communities. The first rodent studies 6,7 showing that soy protein lowered cholesterol levels were published more than 60 years ago, and the first clinical trial demonstrating this effect was published in Throughout the 1970s and 1980s, Italian researchers were instrumental in showing that soy protein directly lowered blood cholesterol levels in very hyper-cholesterolemic patients Nevertheless, it wasn t until 1995 that the cholesterollowering effects of soy protein received widespread recognition. In that year, a meta-analysis of the clinical data, which included 38 different comparisons, found that soy protein reduced low-density lipoprotein cholesterol (LDLC) by approximately 13 percent. 12 This reduction was independent of the fatty acid content of soyfoods and, because statins were not yet widely used in clinical practice, the effect of soy protein was similar to that of the available cholesterol-lowering medications. The results of the 1995 meta-analysis prompted much investigation into the cholesterol-lowering effects of soy protein. Some of this research has been directed at identifying the specific soybean components and mechanisms responsible for cholesterol reduction, whereas other research explored the responses to soy protein in different subpopulations such as hypercholesterolemic individuals and pre- and postmenopausal women. In regard to mechanism, some data suggest that cholesterol reduction is a result of the upregulation of hepatic LDL 13, 14 receptors by the peptides formed upon digestion of soy protein. Researchers also continue to explore whether isoflavones in soybeans impact the cholesterol-lowering effects of soy protein. 15 Soyfoods are uniquely rich sources of these diphenolic compounds. 16 In 1999, the U.S. Food and Drug Administration (FDA) approved a health claim for soyfoods and CHD based on the cholesterol-lowering effects of soy protein. 17 Claims similar to the FDA claim have been approved in >10 other countries, 18 including most recently Canada, which did so in However, despite the large amount of research upon which the FDA health claim was based, the cholesterollowering ability of soy protein has been challenged in recent years. Some inconsistency in the literature is expected given that many trials involved relatively small sample sizes and that in general about 20% of individuals whose cholesterol levels are elevated do not respond to dietary changes. 20 In 2008, the American Heart Association (AHA) formally expressed their opposition to the existing soy health claim. In their 2006 position paper, the AHA acknowledged the important role soyfoods can have in heart-healthful diets because they are low in saturated fat and high in polyunsaturated fat (PUFA). 21 However, the decrease in LDLC in 2
3 response to soy protein, which they estimated to be approximately 3%, based on the results of 22 studies, was insufficient in their view to warrant a health claim. 21 The AHA endorsed the health claim in 2000 shortly after it was first issued. 22 Importantly, however, the AHA did not conduct a formal statistical meta-analysis of the 22 studies upon which they based their estimate of the potency of soy protein. When such an analysis was conducted, Jenkins et al. 23 found that the AHA had considerably underestimated the hypocholesterolemic effects of soy protein since the analysis showed that soy protein lowered LDLC by 4.3 percent. Furthermore, when the analysis was limited to the 11 studies that provided evidence that the control and soy diets were matched for nutrient content, soy protein was found to lower LDLC by 5.2 percent. Over the past decade or so, all of the meta-analyses of the clinical data have found soy protein statistically significantly lowers LDLC. 19, A conservative estimate based on the results of these analyses is that soy protein lowers LDLC approximately 4%, which is similar to the effects of soluble fiber, which also has a health claim. 27 Since each 1% decrease in LDLC lowers CHD risk by 1-3%, incorporating soy protein into the diet 28, 29 can substantially reduce CHD morbidity and mortality. the displacement of traditional sources of protein in Western diets (which tend to be high in saturated fat) by soyfoods and the direct effects of soy protein, soyfoods can be expected to decrease LDLC by approximately 8 percent. In recent years there has been considerable controversy about the impact of saturated fat on CHD risk with some analyses finding no relationship. 37 Certainly, it is recognized that not all dietary saturated fatty acids exert the same effect on serum LDLC. 38 In addition, the impact of dietary saturated fatty acids on serum LDLC depends upon the type and composition of food in which the saturated fat is consumed. For example, saturated fat in butter raises LDLC to a much greater extent than saturated fat in cheese. 39 This finding has been attributed to the high calcium content of cheese, which can form insoluble salts with the saturated fatty acids, preventing them from being absorbed. 40 Finally, research shows that soy protein modestly raises high density lipoprotein cholesterol and lowers circulating triglyceride levels. In addition, soy protein was found to decrease postprandial triglyceride levels, elevated levels of which are increasingly viewed as important for reducing CHD risk. 30 EFFECTS OF SOY FAT ON CHD RISK In contrast to other legumes which are nearly fat-free, approximately 40% of the calories from soybeans are comprised of fat. 31 The fatty acid composition of soy is very heart-healthy as it is comprised of only 12% saturated fat, 29% monounsaturated fat and 59% PUFA (53% linoleic acid and 6% α-linolenic acid). 32 The soybean is one of the few good sources of both essential fatty acids and, because of its widespread use in the United States, soy oil accounts for over 40% of the intake of both essential fatty acids. 33 Although the omega-3 fatty acid α-linolenic acid (ALA) does not possess the same properties as the long-chain omega-3 fatty acids found in cold-water fish, evidence suggests that ALA has direct coronary benefits; the degree is a matter of some debate In 2010, using National Health and Nutrition Examination Survey III population data, Jenkins et al., 23 estimated that as a result of differences in fatty acid intake, when soyfoods replace more traditional sources of protein in the Western diet, LDLC is reduced by 3 to 6 percent. There was a 4% reduction in LDLC when 24g soy protein an amount similar to the 25g/day established by FDA as the threshold intake for cholesterol reduction replaced a comparable amount of the more commonly consumed protein sources. Thus, as a result of 3
4 While it is far beyond the scope of this review to examine the relationship between dietary fatty acid intake and CHD risk in depth, data indicate that the impact of saturated fat is dependent upon that which replaces it. To this point, a combined analysis of the Nurses Health Study (1980 to 2010, n=84,628) and the Health Professionals Follow-up Study (1986 to 2010, n= 42,908 men) found that replacing 5% of energy intake from saturated fats with equivalent energy intake from PUFA, monounsaturated fat, or carbohydrates from whole grains was associated with a 25%, 15%, and 9% lower risk of CHD, respectively, whereas replacing saturated fat with carbohydrates from refined starches/added sugars was not significantly associated with CHD risk. 41 Interestingly, a recent analysis found that in many countries around the world inadequate intake of PUFA contributes much more to CHD mortality than an excess intake of saturated fat. 42 Thus, full-fat soyfoods and soybean oil can markedly help to reduce risk of developing CHD. Nevertheless, despite soy s cholesterol-lowering effect, some concerns have arisen that too much omega-6 PUFA and, in particular, linoleic acid, may increase CHD risk by increasing inflammation. However, the AHA has rejected concerns about the pro-inflammatory properties of linoleic acid and concluded that omega-6 PUFA plays a critically important role in heart-healthful diets. 43 This position is supported by a comprehensive review by Johnson and Fritsche, 44 published in 2012, which concluded that virtually no evidence is available from randomized, controlled intervention studies among healthy, non-infant human beings to show that addition of LA [linoleic acid] to the diet increases the concentration of inflammatory markers. One reason for this lack of effect may be because, although linoleic acid is converted to arachidonic acid (AA) from which a number of proinflammatory eicosanoids are produced, tissue levels of AA don t substantially increase because they are tightly regulated. 45 Also, it is now recognized that not all of the eicosanoids produced from AA are pro-inflammatory; some in fact may be anti-inflammatory. 46 Interestingly, in eightweek-old male C57Bl/6 mice, diets high in saturated and monounsaturated fat increased pro-inflammatory markers in the liver and adipose tissue whereas no such effects were noted in animals fed diets high in linoleic acid. 4 4
5 BEYOND EFFECTS ON LIPID LEVELS There is epidemiologic evidence that soyfoods exert coronary benefits independent of their effect on blood cholesterol levels. For example, In Shanghai, a prospective study involving nearly 65,000 postmenopausal women found after controlling for a variety of factors that soy protein intake was associated with an 86% reduction in the risk of non-fatal myocardial infarction. 48 In China, a cross-sectional study involving 406 adults ages 40 to 65 years old (134 males, 272 females) without confirmed relevant diseases, found that soyfood intake was inversely related to bifurcation intima-media thickness, although the association was more apparent in men than women. 49 In Japan, a prospective study involving 40,462 participants, ages 40 to 59 years old without cardiovascular disease or cancer at baseline, found that when comparing women with frequent ( 5x/week) versus infrequent ( 2x/week) soy consumption, the multivariable hazard ratios were 0.64, 0.55 and 0.31 for risk of the incidence of cerebral infarction, myocardial infarction and CHD mortality, respectively. 50 However, there was only a nonsignificant trend toward a protective effect of soy among men. In contrast to the above studies, in Singapore, a prospective study involving 63,257 Chinese adults aged years, found soy intake was unrelated to mortality in either men or women after 890,473 person-years of follow-up. 51 Also, a large prospective study from Shanghai found that over the 5.4-year follow-up period, soy intake was associated with an increased risk of CHD among men. 52 This finding comes from a study that was published as a letter to the editor and is inconsistent with the prospective studies from Japan 50 and Singapore; 51 nevertheless, this result warrants additional investigation. For at least two reasons, it is highly unlikely that the cholesterollowering effects of soyfoods were primarily responsible for the protective effects observed in the prospective studies from Japan 50 and Shanghai 48 and the cross-sectional study from China. 49 First, soy protein consumption in the upper intake categories was between eight and 16g/day, which, based on the results from the clinical studies, is likely too little to lower cholesterol. Second, the protective effects were far greater than could be expected from the cholesterol reduction typically associated with soy protein. Perhaps the explanation is a healthy user effect, i.e., that soyfood consumption is associated with an overall healthier lifestyle. This explanation is unlikely, however, because most of the studies controlled for a wide range of potentially confounding variables. Also, soy consumption in Asia is much less reflective of an overall lifestyle than it is in countries where soyfoods have not been part of the traditional diet. 5
6 BLOOD PRESSURE In support of the epidemiologic studies, which found inverse relationships between CHD risk and soy intake, are various clinical studies that show soyfoods, soy protein or soybean isoflavones favorably affect a number of biological measures that impact heart disease risk. For example, four recently published meta-analyses concluded that soy modestly lowers blood pressure In the largest of these, which included 27 studies, soy lowered systolic and diastolic blood pressure by 2.21 and 1.44 mghg, respectively. 54 Reducing systolic blood pressure by just 2-5mmHg may reduce stroke and CHD disease by 6-14% and 5-9%, respectively. 57 ENDOTHELIAL FUNCTION (VASODILATION) Two meta-analyses have found that soybean isoflavones improved endothelial function in postmenopausal women. 58, 59 Endothelial cells line the blood vessels and their functioning can impact CHD risk. When the data from one of these meta-analyses were sub-analyzed, the improvement was only found in those women who had impaired endothelial function at baseline. 58 Of course, these women are at greater risk of having or developing CHD. This finding provides an explanation for the inconsistent literature in that some studies included women with both impaired endothelial function and others with normal endothelial function. It may also be that some of the observed anti-inflammatory effects of isoflavones occur only in people at risk of CHD who have elevated levels of inflammatory markers. 60 6
7 ARTERIAL COMPLIANCE Unlike endothelial-mediated vasodilation (primarily nitric oxidedependent), arterial compliance relates to the constriction and dilation of arteries associated with systole and diastole. Arterial compliance is determined by components of the artery wall, such as elastin, proteoglycans and smooth muscle cell function. The most straightforward, valid, and reliable measure of arterial stiffness is pulse wave velocity (PWV), which is predictive of future cardiovascular events. 61 First, it adds substantially to the biologically plausibility of the findings and second, it provides clear insight into the soy component responsible for the beneficial effects. The pronounced effect in early menopausal women suggests isoflavones were primarily responsible for the reduced CIMT progression because over the past 15 years a hypothesis has emerged, referred to as the estrogen timing hypothesis, which maintains that exposure to estrogen-like compounds leads to dramatic coronary benefits when begun soon after menopause, but has less effect in later years. 72 In 2011, a systematic review by Pase et al. 62 concluded on the basis of five studies that isoflavones reduce arterial stiffness, although one of the four that reported benefit intervened with an isoflavone metabolite. 67 Three additional studies not reviewed by Pase et al. 62 are supportive of the ability of isoflavones to improve arterial compliance in postmenopausal women Conversely, no differences in arterial compliance were noted in a small group of hypercholesterolemic men and women when comparing a soymilk/soy yogurt intervention with a dairy milk/yogurt intervention. 71 CAROTID INTIMA-MEDIA THICKNESS Subclinical atherosclerosis can be assessed using ultrasound to measure the thickness of the carotid arteries, which are located on both sides of the neck beneath the jawline and provide the main blood supply to the brain. The thickness of the carotid artery is referred to as carotid intima-media thickness or CIMT. Typically, CIMT increases or progresses over time; the extent of progression reflects risk of future coronary events. An important clinical trial to evaluate the impact of soy on CIMT is the Women s Isoflavone Soy Health (WISH) study, a 3-year study involving 350 healthy postmenopausal women ages 45 to 92. Based on changes in CIMT, this study found that isoflavone-rich soy protein inhibited the progression of subclinical atherosclerosis. 72 Participants in the WISH study were randomly assigned to groups consuming either 25g of isolated soy protein or 25g of milk protein per day. The soy protein provided 91mg of isoflavones (expressed in aglycone equivalent weight). At study termination, progression among the women consuming soy was 16% lower than in the milk group. Furthermore, the difference between groups increased steadily over the 3-year study period. This suggests that after a longer period of soy exposure, progression would have been reduced to an even greater extent, and with it, risk of coronary events. Additionally, subanalysis of the results revealed that among women who were fewer than five years, five to 10 years, and more than 10 years post-menopause, CIMT progression was reduced by 68 (p=0.05), 17 (p=0.51) and 9% (p=0.77), respectively. That progression was reduced so significantly in early postmenopausal women is notable for two reasons. SUMMARY AND CONCLUSIONS In summary, soyfoods can make important contributions to hearthealthful diets through several different mechanisms. They provide high-quality protein but minimal amounts of saturated fat. They provide ample amounts of omega-6 and omega-3 essential fatty acids. Soy protein directly lowers blood LDLC levels, modestly elevates high density lipoprotein cholesterol levels and decreases triglyceride levels. Furthermore, soyfoods appear to favorably affect CHD risk factors independent of lipid levels; for example, improving endothelial function and systematic arterial compliance and lowering blood pressure. 7
8 References 1. Mathers, C.D. and D. Loncar, Projections of global mortality and burden of disease from 2002 to PLoS Med, (11): p. e MacMahon, S., et al., Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet, (8692): p Mozaffarian, D., et al., Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation, (4): p. e38-e Mehta, L.S., et al., Acute myocardial infarction in women: A scientific statement from the American Heart Association. Circulation, Pan, W.H., et al., Diet and health trends in Taiwan: comparison of two nutrition and health surveys from and Asia Pac J Clin Nutr, (2): p Meeker, D.R. and D. Kesten, Effect of high protein diets on experimental atherosclerosis of rabbits. Arch Pathol, : p Meeker, D.R. and H.D. Kesten, Experimental atherosclerosis and high protein diets. Proc Soc Exp Biol Med, : p Hodges, R.E., et al., Dietary carbohydrates and low cholesterol diets: effects on serum lipids on man. Am J Clin Nutr, (2): p Sirtori, C.R., et al., Soybean-protein diet in the treatment of type-ii hyperlipoproteinaemia. Lancet, (8006): p Sirtori, C.R., et al., Clinical experience with the soybean protein diet in the treatment of hypercholesterolemia. Am J Clin Nutr, (8): p Sirtori, C.R., et al., Cholesterol-lowering and HDL-raising properties of lecithinated soy proteins in type II hyperlipidemic patients. Ann Nutr Metab, (6): p Anderson, J.W., B.M. Johnstone, and M.E. Cook-Newell, Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med, (5): p Cho, S.J., M.A. Juillerat, and C.H. Lee, Cholesterol lowering mechanism of soybean protein hydrolysate. J Agric Food Chem, (26): p Manzoni, C., et al., Subcellular Localization of Soybean 7S Globulin in HepG2 Cells and LDL Receptor Up- Regulation by Its alpha Constituent Subunit. J Nutr, (7): p Zhuo, X.G., M.K. Melby, and S. Watanabe, Soy Isoflavone Intake Lowers Serum LDL Cholesterol: A Meta- Analysis of 8 Randomized Controlled Trials in Humans. J Nutr, (9): p Kuiper, G.G., et al., Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, (10): p Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease, in Federal Register: (Volume 64, Number 206)]1999. p Xiao, C.W., Health effects of soy protein and isoflavones in humans. J Nutr, (6): p. 1244S-9S. 19. Benkhedda, K.B., B, et al., Food Risk Analysis Communication. Issued By Health Canada s Food Directorate. Health Canada s Proposal to Accept a Health Claim about Soy Products and Cholesterol Lowering. Int Food Risk Anal J, :22 doi: / Denke, M.A., B. Adams-Huet, and A.T. Nguyen, Individual cholesterol variation in response to a margarine- or butter-based diet: A study in families. JAMA, (21): p Sacks, F.M., et al., Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation, (7): p Erdman, J.W., Jr., Soy protein and cardiovascular disease: A statement for healthcare professionals from the nutrition committee of the AHA. Circulation, (20): p Jenkins, D.J., et al., Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr, (12): p. 2302S-2311S. 24. Anderson, J.W. and H.M. Bush, Soy protein effects on serum lipoproteins: A quality assessment and metaanalysis of randomized, controlled studies. J Am Coll Nutr, (2): p Zhan, S. and S.C. Ho, Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr, (2): p Harland, J.I. and T.A. Haffner, Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis, (1): p Brown, L., et al., Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr, (1): p Law, M.R., N.J. Wald, and S.G. Thompson, By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ, (6925): p Law, M.R., et al., Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ, (6925): p Santo, A.S., et al., Postprandial lipemia detects the effect of soy protein on cardiovascular disease risk compared with the fasting lipid profile. Lipids, (12): p Messina, M.J., Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr, (3 Suppl): p. 439S-450S. 32. Hayes, K.C., Dietary fatty acids, cholesterol, and the lipoprotein profile. Br J Nutr, (4): p Blasbalg, T.L., et al., Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr, (5): p Brouwer, I.A., M.B. Katan, and P.L. Zock, Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr, (4): p Holguin, F., et al., Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest, (4): p Whelan, J., Dietary stearidonic acid is a long chain (n-3) polyunsaturated fatty acid with potential health benefits. J Nutr, (1): p Chowdhury, R., et al., Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med, (6): p Kris-Etherton, P.M. and S. Yu, Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr, (5 Suppl): p. 1628S-1644S. 39. Hjerpsted, J., E. Leedo, and T. Tholstrup, Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content. Am J Clin Nutr, (6): p Soerensen, K.V., et al., Effect of dairy calcium from cheese and milk on fecal fat excretion, blood lipids, and appetite in young men. Am J Clin Nutr, (5): p Li, Y., et al., Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart Disease: A prospective cohort study. J Am Coll Cardiol, (14): p Wang, Q., et al., Impact of nonoptimal intakes of saturated, polyunsaturated, and trans fat on global burdens of coronary heart disease. J Am Heart Assoc, (1). 43. Harris, W.S., et al., Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation, (6): p Johnson, G.H. and K. Fritsche, Effect of dietary linoleic acid on markers of inflammation in healthy persons: A systematic review of randomized controlled trials. J Acad Nutr Diet, : p Rett, B.S. and J. Whelan, Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review. Nutr Metab (Lond), : p Harris, W.S. and G.C. Shearer, Omega-6 fatty acids and cardiovascular disease: friend, not foe? Circulation, (18): p Vaughan, R.A., et al., A high linoleic acid diet does not induce inflammation in mouse liver or adipose tissue. Lipids, (11): p Zhang, X., et al., Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr, (9): p Zhang, B., et al., Greater habitual soyfood consumption is associated with decreased carotid intima-media thickness and better plasma lipids in Chinese middle-aged adults. Atherosclerosis, (2): p Kokubo, Y., et al., Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation, (22): p Talaei, M., et al., Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. J Nutr, (6): p Lewington, S., et al., Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, (9349): p Hooper, L., et al., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr, (1): p Dong, J.Y., et al., Effect of soya protein on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr, (3): p Taku, K., et al., Effects of soy isoflavone extract supplements on blood pressure in adult humans: systematic review and meta-analysis of randomized placebo-controlled trials. J Hypertens, (10): p Liu, X.X., et al., Effect of soy isoflavones on blood pressure: A meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis, (6): p Stamler, R., Implications of the INTERSALT study. Hypertension, (1 Suppl): p. I Li, S.H., et al., Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am J Clin Nutr, (2): p Beavers, D.P., et al., Exposure to isoflavone-containing soy products and endothelial function: A Bayesian metaanalysis of randomized controlled trials. Nutr Metab Cardiovasc Dis, (3): p Fuchs, D., et al., Proteomic biomarkers of peripheral blood mononuclear cells obtained from postmenopausal women undergoing an intervention with soy isoflavones. Am J Clin Nutr, (5): p Vlachopoulos, C., K. Aznaouridis, and C. Stefanadis, Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol, (13): p Pase, M.P., N.A. Grima, and J. Sarris, The effects of dietary and nutrient interventions on arterial stiffness: a systematic review. Am J Clin Nutr, (2): p Teede, H.J., et al., Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebocontrolled study in men and postmenopausal women. J Clin Endocrinol Metab, (7): p Teede, H.J., et al., Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol, (6): p Tormala, R., et al., Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation. Atherosclerosis, (1): p Nestel, P.J., et al., Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol, (12): p Nestel, P., A. Fujii, and L. Zhang, An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women. Atherosclerosis, (1): p Nestel, P.J., et al., Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab, (3): p Curtis, P.J., et al., Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial. Am J Clin Nutr, (5): p Reverri, E.J., et al., Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk. Mol Nutr Food Res, (2): p Meyer, B.J., et al., Limited lipid-lowering effects of regular consumption of whole soybean foods. Ann Nutr Metab, (2): p Hodis, H.N. and W.J. Mack, A window of opportunity: The reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent. Brain Res, : p The 70 farmer-directors of USB oversee the investments of the soy checkoff to maximize profit opportunities for all U.S. soybean farmers. These volunteers invest and leverage checkoff funds to increase the value of U.S. soy meal and oil, to ensure U.S. soybean farmers and their customers have the freedom and infrastructure to operate, and to meet the needs of U.S. soy s customers. As stipulated in the federal Soybean Promotion, Research and Consumer Information Act, the USDA Agricultural Marketing Service has oversight responsibilities for USB and the soy checkoff. For more information, please visit SoyConnection.com
Traditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( )
Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com 1000 80 20 60 40 40 60 20 80
More informationProven and Proposed Cardiovascular Benefits of Soyfoods
Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com Alpro Foundation 20 years symposium
More informationOverview of the cholesterol lowering effect of soy protein and perspective on the FDA s evaluation of the clinical data
Overview of the cholesterol lowering effect of soy protein and perspective on the FDA s evaluation of the clinical data Mark Messina, PhD, MS Soy Nutrition Institute Nutrition Matters, Inc. Loma Linda
More informationSOYBEAN OIL FACTS CONVENTIONAL SOYBEAN OIL
SOYBEAN OIL FACTS CONVENTIONAL SOYBEAN OIL Versatile Oil Solution Soybean oil is the most widely used edible oil in the U.S.1 It blends well with other fats and oils, making it a common ingredient in margarine
More informationSOYBEAN OIL FACTS CONVENTIONAL SOYBEAN OIL
OIL FACTS CONVENTIONAL OIL Versatile Oil Solution Soybean oil is the most widely used edible oil in the U.S. 1 It blends well with other fats and oils, making it a common ingredient in margarine and shortenings,
More informationHIGH OLEIC and INCREASED OMEGA-3
SOYBEAN OIL FACTS HIGH OLEIC and INCREASED OMEGA-3 SOYBEAN OILS Soybean Oil Innovations The soybean industry recognizes the need to provide healthful and functional ingredients to the food industry, and
More informationNEWS & VIEWS. Hole in the diet-heart hypothesis?
NEWS & VIEWS Hole in the diet-heart hypothesis? Philip C. Calder Faculty of Medicine, University of Southampton, MP887 Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom and
More informationFacts on Fats. Ronald P. Mensink
Facts on Fats Ronald P. Mensink Department of Human Biology NUTRIM, School for Nutrition, Toxicology and Metabolism Maastricht University Maastricht The Netherlands Outline of the Presentation Saturated
More informationTHE SAME EFFECT WAS NOT FOUND WITH SPIRITS 3-5 DRINKS OF SPIRITS PER DAY WAS ASSOCIATED WITH INCREASED MORTALITY
ALCOHOL NEGATIVE CORRELATION BETWEEN 1-2 DRINKS PER DAY AND THE INCIDENCE OF CARDIOVASCULAR DISEASE SOME HAVE SHOWN THAT EVEN 3-4 DRINKS PER DAY CAN BE BENEFICIAL - WHILE OTHERS HAVE FOUND IT TO BE HARMFUL
More informationWhere are we heading?
Unit 5: Where are we heading? Unit 5: Introduction Unit 1: What s in your food? Unit 2: How does your body use food? Unit 3: What is metabolic disease? Unit 4: How do I identify good and bad food? Unit
More informationSoybean Oil Facts: HIGH OLEIC and INCREASED OMEGA-3 SOYBEAN OILS
Soybean Oil Facts: HIGH OLEIC and INCREASED OMEGA-3 SOYBEAN OILS Soybean Oil Innovations HIGH OLEIC The soybean industry recognizes the need to provide healthful and functional ingredients to the food
More informationTECHNICAL REPORT OF EFSA
Supporting Publications 2012:305 TECHNICAL REPORT OF EFSA Response to comments on the Scientific Opinion on the substantiation of a health claim related to isolated soy protein and reduction of blood LDLcholesterol
More informationFuture directions for nutritional and therapeutic research in omega-3 3 lipids
Future directions for nutritional and therapeutic research in omega-3 3 lipids Philip Calder Professor of Nutritional Immunology University of Southampton Aim To review dietary sources and intakes of long
More informationCardiac patient quality of life. How to eat adequately?
Cardiac patient quality of life How to eat adequately? François Paillard CV Prevention Center CHU Rennes JESFC, Paris, 17/01/2013 Mrs. L. 55 yrs, Coronary artery disease, normal weight, mild hypertension
More information13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:
CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation
More informationWhat should I eat? I am so confused. Jennifer Lyon DO
What should I eat? I am so confused. Jennifer Lyon DO Conflict of Interest Disclosure I have no conflict of interest to report Overview 2015-2020 Dietary Guidelines 5 primary guidelines Sugar intake Sodium
More informationSOY for Health Make the Soy Connection SoyConnection.com
SOY for Health Make the Soy Connection SoyConnection.com INTRODUCTION Soyfoods have long been important in Asian diets, where they are valued for their nutrient content and culinary versatility. For health-conscious
More informationAmerican Diabetes Association: Standards of Medical Care in Diabetes 2015
American Diabetes Association: Standards of Medical Care in Diabetes 2015 Synopsis of ADA standards relevant to the 11 th Scope of Work under Task B.2 ASSESSMENT OF GLYCEMIC CONTROL Recommendations: Perform
More informationDietary Reference Values: a Tool for Public Health
HOGE GEZONDHEISRAAD Dietary Reference Values: a Tool for Public Health CONSEIL SUPERIEUR DE LA SANTE Belgian Dietary Reference Values for Energy and Macronutrients: FATS G. De Backer Brussels, February
More informationHealthy Fats & Fatty Acids Current Dietary Recommendations and Popular Opinions
Healthy Fats & Fatty Acids Current Dietary Recommendations and Popular Opinions Presentation 1 of 2 Penny M. Kris-Etherton PhD RD FAHA FNLA FASN CLS Department of Nutritional Sciences Penn State University
More informationThe impact of dairy products on cardiovascular health
The impact of dairy products on cardiovascular health D Vasilopoulou 2014 1 Overview CVD mortality in UK Does dairy consumption increase the risk of CVD? Dairy intake as part of healthy lifestyle RESET
More informationJuly 13, Dear Ms. Davis:
July 13, 2010 Carole Davis Co-Executive Secretary and Designated Federal Officer of the Dietary Guidelines Advisory Committee Center for Nutrition Policy and Promotion U.S. Department of Agriculture 3101
More informationEssential Fatty Acids Essential for Good Health SIE
Page 1 of 6 Essential Fatty Acids Essential for Good Health SIE By Yousry Naguib, PhD Essential fatty acids (EFAs) must be obtained through the diet and cannot be synthesized by the human body. EFAs are
More informationFLAXSEED Health Benefits and Functionality. Kelley C. Fitzpatrick Director of Health FLAX COUNCIL OF CANADA
FLAXSEED Health Benefits and Functionality Kelley C. Fitzpatrick Director of Health FLAX COUNCIL OF CANADA Consumers are interested in Positive Nutrition The trend is no longer just to remove bad ingredients
More informationSaturated fat- how long can you go/how low should you go?
Saturated fat- how long can you go/how low should you go? Peter Clifton Baker IDI Heart and Diabetes Institute Page 1: Baker IDI Page 2: Baker IDI Page 3: Baker IDI FIGURE 1. Predicted changes ({Delta})
More informationMilk and Dairy for Cardiometabolic Health
Milk and Dairy for Cardiometabolic Health Anne Mullen, BSc, PhD, FHEA, RD Director of Nutrition at The Dairy Council November 2016 Email: a.mullen@dairycouncil.org.uk Tel: 020 7025 0560 Web: www.milk.co.uk
More informationMetabolic Health: The impact of Dairy Matrix. Arne Astrup, MD, DMSc Head of department & professor. Department of Nutrition, Exercise and Sports
Department of Nutrition, Exercise and Sports Metabolic Health: The impact of Dairy Matrix 3 October 2017 Dias 1 Arne Astrup, MD, DMSc Head of department & professor Department of Nutrition, Exercise and
More informationGoing Coconut over Saturated Fat? Why So Much Confusion? Part 1 Interpreting Conflicting Research
Going Coconut over Saturated Fat? Why So Much Confusion? Part 1 Interpreting Conflicting Research Disclosures Alice H Lichtenstein Board Member/Advisory Panel Food and Nutrition Board, National Academies
More informationMetabolic Health: The impact of Dairy Matrix. Arne Astrup, MD, DMSc Head of department & professor. Department of Nutrition, Exercise and Sports
Metabolic Health: The impact of Dairy Matrix 1 November 2017 Dias 1 Arne Astrup, MD, DMSc Head of department & professor EFSA: As low as possible 1 November 2017 Dias 2 People don t want to hear the truth
More informationLipids Types, Food Sources, Functions
Lipids Types, Food Sources, Functions What Are Lipids? Lipids Diverse group of molecules that are insoluble in water Fats The lipid content of diets and foods 1 Lipids in Body Cells and Tissues Types of
More informationPattern of lipid biomarkers and risk of cardiovascular disease
Pattern of lipid biomarkers and risk of cardiovascular disease Robert Clarke Clinical Trial Service Unit University of Oxford 9 January 2017 Biomarkers for dietary fats Blood lipids (LDL, HDL, triglycerides,
More informationSTAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP
STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP What is Heart Disease Cardiovascular Disease (CVD): Heart or Blood vessels are not working properly. Most common reason
More informationFatty acids and cardiovascular health: current evidence and next steps
Fatty acids and cardiovascular health: current evidence and next steps Emanuele Di Angelantonio, MD, PhD Department of Public Health and Primary Care NICE guidelines on fatty acids Eliminate the use of
More informationCan foods change your health? Good fats and bad fats: what is the evidence? Kay-Tee Khaw. Main categories of fats
Can foods change your health? Good fats and bad fats: what is the evidence? Kay-Tee Khaw UNIVERSITY OF CAMBRIDGE Hong Kong July 6 213 Yerushalmy J Hilleboe HE NY State J Med 1957 Coronary heart disease
More informationFatty acids, cardiovascular disease and diabetes
Fatty acids, cardiovascular disease and diabetes Rajiv Chowdhury, Nita Forouhi 28 th October 2015 Workshop on nutritional biomarkers A joint PHRI/MRC Epidemiology Unit Initiative Population nutrient goal
More informationSOYBEAN OIL FACTS PROCESSING SOLUTIONS
SOYBEAN OIL FACTS PROCESSING SOLUTIONS to Remove Partially Hydrogenated Oils from the Food Supply Replace Partially Hydrogenated Oils with Soy-Based Solutions Made with U.S.-Grown Soybeans The soybean
More informationDiet, nutrition and cardio vascular diseases. By Dr. Mona Mortada
Diet, nutrition and cardio vascular diseases By Dr. Mona Mortada Contents Introduction Diet, Diet, physical activity and cardiovascular disease Fatty Fatty acids and dietary cholesterol Dietary Dietary
More informationStatins and Cholesterol. Noreen Devanney Primary Care Pharmacist Surrey Heath CCG
Statins and Cholesterol Noreen Devanney Primary Care Pharmacist Surrey Heath CCG What are Statins? Statins are drugs that lower cholesterol They act on the liver to decrease production Usually act within
More informationEffects of whole grain intake on weight changes, diabetes, and cardiovascular Disease
Effects of whole grain intake on weight changes, diabetes, and cardiovascular Disease Simin Liu, MD, ScD Professor of Epidemiology and Medicine Director, Center for Global Cardiometabolic Health Brown
More informationDairy matrix effects on T2 diabetes and cardiometabolic health?
Department of Nutrition, Exercise and Sports Dairy matrix effects on T2 diabetes and cardiometabolic health? Arne Astrup Head of department, professor, MD, DMSc. Department of Nutrition, Exercise and Sports
More informationComposition and Structure of Oil and Fats and its Relationship to Health and Nutrition
Composition and Structure of Oil and Fats and its Relationship to Health and Nutrition SB Neoh* & K. Sundram** * Managing Director, Soon Soon Oilmills Sdn Bhd, Malaysia **Deputy CEO and Director, Science
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More informationMaintain Cholesterol
Maintain Cholesterol What is Cholesterol? Cholesterol is a Lipid Molecule that has a waxy appearance and is found in every cell of the body and has some important natural functions. It is manufactured
More informationDiabetes Mellitus: A Cardiovascular Disease
Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular
More informationSession 21: Heart Health
Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk
More informationChronic Disease and Nutritional Underpinnings. Patrick Gélinas Dept. of Exercise and Sports Science USC Aiken
Chronic Disease and Nutritional Underpinnings Patrick Gélinas Dept. of Exercise and Sports Science USC Aiken Modern Diseases Difficult (impossible?) to gain information regarding diseases among prehistoric
More informationA Fresh Perspective. Lean Beef and Heart Health: ... Fresh red meat is not associated with CHD risk
Spring 2012... Fresh red meat is not associated with CHD risk R Lean Beef and Heart Health: A Fresh Perspective esearchers from the Harvard School of Public Health recently concluded that consuming 100
More informationFats and Other Lipids
Fats and Other Lipids Chapter 6 Chapter 6: Fats and other Lipids 1 6.1 Understanding Lipids Lipids include: 1. Fatty acids 2. Triglycerides 3. Phospholipids 4. Cholesterol Oil and Water Don t Mix Because
More informationOptimize Your Omega-3 Status Personalized Blood Test Reveals a Novel Cardiac Risk Factor
http://www.lef.org/ Life Extension Magazine May 2010 Optimize Your Omega-3 Status Personalized Blood Test Reveals a Novel Cardiac Risk Factor By Julius Goepp, MD Suppose you could assess with precision
More informationLipids. PBHL 211 Darine Hachem, MS, LD
Lipids PBHL 211 Darine Hachem, MS, LD Outline Functions of lipids in our body Types of lipids Sources of lipids Recommendation of fat intake Fat association with heart diseases Provide energy (9Kcal/g
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationLOWERS FAST C O KEEPS LOW O C O. Benecol provides fast results and. dietary way to lower cholesterol. For healthcare professionals
C O O LOWERS FAST O C O KEEPS LOW Benecol provides fast results and keeps Benecol cholesterol - Effective at lower and level, easy naturally dietary way to lower cholesterol For healthcare professionals
More informationModifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health
Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health Robert Clarke Clinical Trial Service Unit University of Oxford 28 th May
More informationSoyfoods AND YOUR HEALTH
Soyfoods AND YOUR HEALTH Soybean History Soybeans were first domesticated in Northern China around the 11th century B.C., and within 1500 years had been introduced throughout much of Southeast Asia. Today,
More informationName of Policy: Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor
Name of Policy: Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor Policy #: 239 Latest Review Date: July 2010 Category: Laboratory Policy Grade: Active
More informationRole of Dietary Fats and Cardiovascular Risk
Role of Dietary Fats and Cardiovascular Risk Julie Lovegrove Hugh Sinclair Unit of Human Nutrition & Institute for Cardiovascular and Metabolic Research University of Reading, UK Alpro Student Symposium
More informationCHOLESTEROL GUIDELINES
CHOLESTEROL GUIDELINES High cholesterol and lipid levels can significantly increase a person's risk of developing chest pain, heart attack, and stroke. Fortunately, a number of effective treatment options
More informationKey Nutritional Considerations & Lab Markers as Adjuncts in Effective Lipid Management. Carmen Ritz, MS Clinical Physiologist
Key Nutritional Considerations & Lab Markers as Adjuncts in Effective Lipid Management Carmen Ritz, MS Clinical Physiologist The Ideal Biomarker to identify risk for CVD Specific accurately identifies
More informationHeart Health and Fats
ww Heart Health and Fats By Marie Spano, M.S., R.D., C.S.C.S., Contributing Editor Dietary-fat recommendations for heart health are more specific now then ever, breaking down different types of polyunsaturated
More informationPrevention of Heart Disease. Giridhar Vedala, MD Cardiovascular Medicine
Prevention of Heart Disease Giridhar Vedala, MD Cardiovascular Medicine What is Heart Disease? Heart : The most hard-working muscle of our body pumps 4-5 liters of blood every minute during rest Supplies
More informationMarshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,
Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant
More informationChest pain affects 20% to 40% of the general population during their lifetime.
Chest pain affects 20% to 40% of the general population during their lifetime. More than 5% of visits in the emergency department, and up to 40% of admissions are because of chest pain. Chest pain is a
More informationHIV and Co-morbidities November 18, 2013, 3:10 pm Abstract Number 141
Low omega-3 index in erythrocytes is a risk factor for progression of atherosclerosis in people living with HIV Bianca M Arendt, M Smieja, IE Salit, DWL Ma, F Smaill, D Elston, E Lonn, Johane P Allard
More informationDiet and Non-Communicable Diseases (NCDs): latest evidence
Diet and Non-Communicable Diseases (NCDs): latest evidence Fumiaki Imamura, MS, PhD fumiaki.imamura@mrc-epid.cam.ac.uk 23 Nov 2016, London publications in our field N journals=436 N publications: 90000
More informationAre you eating a balanced diet?
Are you eating a balanced diet? Do you know WHAT A BALANCED DIET IS? Eating a balanced diet means choosing a variety of foods & drinks from all the food groups Health Canada recommends 2-3 Tbsp of oil/day
More informationChapter 2 Nutrition Tools Standards and Guidelines
Chapter 2 Nutrition Tools Standards and Guidelines MULTICHOICE 1. Which of the following statements best describes the recommended dietary allowances (RDA)? (A) they are average nutrient intake goals that
More informationThe WorkCare Group, Inc. Content used with permission. StayWell is a registered trademark of The StayWell Company. All rights reserved.
Know Your Cholesterol Numbers Checklist for Lowering Your Cholesterol Cholesterol Questions to Ask Your Doctor Misconceptions about Cholesterol LDL and HDL Lowering Your Cholesterol CHECKLIST Cut down
More informationANSC/NUTR) 618 LIPIDS & LIPID METABOLISM Dietary fat and Cardiovascular Disease
ANSC/NUTR) 618 LIPIDS & LIPID METABOLISM Dietary fat and Cardiovascular Disease I. Investigations in humans relating dietary fat intake to serum cholesterol A. Ansel Keys: the Keys Formula Cholesterol
More informationNutrition and Health Benefits of Rice Bran Oil. Dr. B. Sesikeran, MD, FAMS Former Director National Institute of Nutrition (ICMR) Hyderabad
Nutrition and Health Benefits of Rice Bran Oil Dr. B. Sesikeran, MD, FAMS Former Director National Institute of Nutrition (ICMR) Hyderabad 1 Fats are needed for life Energy 9 K Cals/g Low fat intakes in
More informationMILK. Nutritious by nature. The science behind the health and nutritional impact of milk and dairy foods
MILK Nutritious by nature The science behind the health and nutritional impact of milk and dairy foods Weight control Contrary to the popular perception that dairy foods are fattening, a growing body of
More informationFAT. Dr. Shamsul Azahari Zainal Badari Department of Resource Management and Consumer Studies Faculty of Human Ecology
FAT Dr. Shamsul Azahari Zainal Badari Department of Resource Management and Consumer Studies Faculty of Human Ecology OBJECTIVES LECTURE By the end of this lecture, student can: Define what is lipid/fat
More informationFree food = 20 calories per serving
FREE FOODS Free food = 20 calories per serving Skimmed butter milk Unsweetened lime / tomato juice Clear Vegetable soup Vegetable salad like tomatoes, cucumber, onion, white radish, lettuce, capsicum.
More informationSUMMARY. Introduction. Study design. Summary
SUMMARY Introduction The global prevalence of type 2 diabetes is increasing rapidly and nowadays affects almost 250 million people. Cardiovascular disease is the most prevalent complication of type 2 diabetes,
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationInsert logo. Linda Main, Dietetic Adviser
Insert logo Linda Main, Dietetic Adviser HEART UK The Cholesterol Charity Our Vision: To prevent avoidable and early deaths caused by high cholesterol. We want the majority of UK adults to know their cholesterol
More information!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants
Aggregate Report Fasting Biometric Screening CLIENTXXXX May 2, 2014 21,000 participants Contact:404.636.9437~Website:www.atlantahealthsys.com RISK FACTOR QUESTIONNAIRE Participants Percent Do not exercise
More informationHow to Prevent Heart Disease
How to Prevent Heart Disease Introduction Heart disease is the leading cause of death worldwide. You can reduce your risk of heart disease with healthy habits. This reference summary explains heart disease
More informationVictor Tambunan. Department of Nutrition Faculty of Medicine Universitas Indonesia
Victor Tambunan Department of Nutrition Faculty of Medicine Universitas Indonesia 1 Handbook of Clinical Nutrition 4th ed., 2006, by D. C. Heimburger & J. A. Ard Krause s Nutrition & Diet Therapy 12th
More informationUNIVERSITY OF CAMBRIDGE. Fatty acids and heart disease. Kay-Tee Khaw
UNIVERSITY OF CAMBRIDGE Fatty acids and heart disease Kay-Tee Khaw Bristol 3 October 2013 Yerushalmy J Hilleboe HE NY State J Med 1957 Coronary heart disease death rates in relation to blood cholesterol
More informationNutrition & Wellness for Life 2012 Chapter 6: Fats: A Concentrated Energy Source
Tools: Printer 8.5 x 11 paper Scissors Directions: 1. Print 2. Fold paper in half vertically 3. Cut along dashed lines Copyright Goodheart-Willcox Co., Inc. All rights reserved. Tissue in which the body
More informationCould plant-based eating meet all our nutritional needs...
Associate Parliamentary Food and Health Forum 18.10.11 Could plant-based eating meet all our nutritional needs... Dr. Janice Harland HARLANDHA ASSOCIATES ...and, if so, should Government advice on healthy
More information10/3/2016. SUPERSIZE YOUR KNOWLEDGE OF the CARDIAC DIET. What is a cardiac diet. If it tastes good, spit it out!!
SUPERSIZE YOUR KNOWLEDGE OF the CARDIAC DIET What is a cardiac diet If it tastes good, spit it out!! 2 1 Heart healthy diet includes: Limiting saturated fat Including unsaturated fats Including omega 3
More informationThe health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences
The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences What should we be promoting? Define health benefits in terms
More informationBuilding Our Evidence Base
Plant-Based Diets Neal D. Barnard, MD, FACC Adjunct Associate Professor of Medicine George Washington University School of Medicine Physicians Committee for Responsible Medicine Washington, DC Building
More informationHEART HEALTH AND HEALTHY EATING HABITS
HEART HEALTH AND HEALTHY EATING HABITS ELIZABETH PASH PENNIMAN RD,LD CLINICAL DIETITIAN Professional Member American Heart Association; Council on Nutrition, Physical Activity and Metabolism PURPOSE: Recognize
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationNutrients and Circulatory Function
Clinical Nutrition Research Centre Nutrients and Circulatory Function Peter Howe Clinical Nutrition Research Centre University of Newcastle Nutritional Physiology Research Centre University of South Australia
More informationOmega-3 Fatty Acids. Alison L. Bailey MD, FACC Erlanger Heart and Lung Institute/University of Tennessee COM
Omega-3 Fatty Acids Alison L. Bailey MD, FACC Erlanger Heart and Lung Institute/University of Tennessee COM Chattanooga @a_l_bailey Disclosures None Objectives Describe omega-3 fatty acids Review the historic
More informationYour cholesterol levels. Questions or concerns
Because you have high cholesterol you should: Know your cholesterol levels Take the medicine to lower cholesterol that your doctor has told you to take Follow your doctor s treatment plan Keep your appointments
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationNutrition Counselling
Nutrition Counselling Frieda Dähler Augustiny, Nutritional Counsellor Preventive Cardiology & Sports Medicine University Clinic of Cardiology Optimal Diet for Prevention of Coronary Heart Disease Diet
More informationAll About Essential Fatty Acids
By Cassandra Forsythe-Pribanic, PhD, RD, CSCS To many people, fat is one of those three-letter words that instils fear of heart disease, obesity, and a lifetime of bad hair days (I m kidding about that
More information1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver)
I. TEST YOUR KNOWLEDGE OF CHOLESTEROL Choose the correct answer. 1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) 2. Only
More informationDairy Intake and Risk Factors for Chronic Disease
Dairy Intake and Risk Factors for Chronic Disease Seminar, Nutrition 566-1 Amber Brouillette Hannah Griswold LETS TAKE A POLL Claims for Dairy Consumption Unnatural Claims Against Cancer development High
More informationThere is more scientific evidence behind the cardiovascular benefits of fish oil than nearly any other nutritional supplement
n Provides optimal support for heart health n Reduces triglyceride levels n Reduces cardiovascular risk factors 7, 8 n Complements statin drug therapy n Optimizes circulation and blood vessel function
More informationSoya foods Global Trends
Soya foods Global Trends Vish Lakshminarayana, So Natural Foods NSW 2229 Abstract Soybeans provide a balanced nutritional profile that can supplement the requirements of protein globally. World wide soybean
More informationNot Hard Choices. By Dato Dr. Rajen M. 27 October 2018
Make Choices Not Hard Choices By Dato Dr. Rajen M. 27 October 2018 Key Facts of Cardiovascular Disease 1. What is the burden of cardiovascular disease in Malaysia? 2. What causes cardiovascular disease?
More information13/05/2013. Dairy Products: Pro- or Anti- Inflammatory Foods? An Overview. Inflammation. Adjusted relative risk of a first cardiovascular event
Relative risk* 13/05/2013 Dairy Products: Pro- or Anti- Inflammatory Foods? An Overview Marie-Ève Labonté, Patrick Couture, Benoît Lamarche INAF, Université Laval STELA Symposium 2013 Delta Centre-Ville,
More informationFats, Oils, Triglycerides. About which Americans seem confused
Fats, Oils, Triglycerides About which Americans seem confused Learning Objectives Define fats and oils Understand triglycerides Consider the benefits of saturated fats Identify trans fats in your food
More informationThe inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema
The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,
More information